Signaling Pathways
-
A1602 Dexrazoxane HCl (ICRF-187, ADR-529)Target: TopoisomerasesSummary: Topoisomerase II inhibitor,intracellular ion chelator,cardioprotective agent
-
A2133 Saracatinib (AZD0530)3 CitationTarget: SrcSummary: Src/Abl inhibitor,potent and selective
-
A1778 Vatalanib (PTK787) 2HClTarget: VEGFRSummary: Tyrosine kinase receptor inhibitor
-
A8019 Perindopril ErbumineTarget: Angiotensin-Converting Enzymes (ACEs)Summary: ACE inhibitor
-
A5354 ZonisamideTarget: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) ChannelsSummary: Antiepileptic with anticonvulsant and mechanistic effect
-
A5181 LinezolidSummary: Antibacterial reagent
-
A5176 AS-605240Target: PI3KSummary: Potent and selective PI 3-Kγ inhibitor
-
A5467 Ponatinib (AP24534)1 CitationTarget: VEGFR|PDGFR|Bcr-Abl|FGFR|SrcSummary: pan-BCR-ABL inhibitor,multi-kinase inhibitor
-
A5424 FludarabineSummary: DNA synthsis inhibitor
-
A5602 SB525334Summary: (TGF-beta1) receptor inhibitor